[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# 3SBio Inc.

3SBio Inc. is raising $XXX million in a stock sale to fund its research and development pipeline. This follows recent positive news about partnerships with Pfizer and progress in its oncology therapies.

### About 3SBio Inc.
3SBio Inc. is a biotechnology company focused on developing innovative therapies, particularly in oncology.  

### Price: $
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/close.tsv)  
The price is likely to increase due to positive news regarding partnerships with Pfizer and progress in the oncology pipeline, as indicated by the supportive social posts.  

1-Year High: $XXXXX on 2025-09-09  
1-Year Low: $XXXX on 2025-01-10  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/alt_rank.tsv)  
3SBio Inc. is currently AltRank #993 based on combined combined social and market metrics
Daily Average: XXXXX  
1-Year High: XXXXX on 2025-01-28  
1-Year Low: XXX on 2025-11-17  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
1-Year High: XXX on 2025-03-24  
1-Year Low: XX on 2025-02-15  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX +19%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXX +88,982%  
1-Year High: XXXXXXX on 2025-05-20  
1-Year Low: X on 2025-02-08  

Engagements by network (24h):
News: X
Reddit: XX
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XXXX%  
X Month: XX -XX%  
X Months: XXX +12%  
X Year: XXX +4,077%  
1-Year High: XXX on 2025-05-20  
1-Year Low: X on 2025-02-08  

Mentions by network (24h):
News: X
Reddit: X
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning 3SBio Inc. in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX -XX%  
X Months: XXX +2.60%  
X Year: XXX +5,086%  
1-Year High: XXX on 2025-05-20  
1-Year Low: X on 2025-02-08  

The most influential creators that mention 3SBio Inc. in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@ForbesAsia](/creator/twitter/ForbesAsia)     | X    | XXXXXX    | X     | XX          |
| [@Generic_Tina](/creator/twitter/Generic_Tina) | X    | XX        | X     | X           |
| [@Byron_Wan](/creator/twitter/Byron_Wan)       | X    | XXXXXX    | X     | X           |
| [@chuminhua432](/creator/twitter/chuminhua432) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$1530hk/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +24%  
X Year: XXX% no change  
1-Year High: XXX% on 2025-02-07  
1-Year Low: XX% on 2025-10-18  

Most Supportive Themes:
- Partnership with Pfizer and Oncology Pipeline Progress: (45%) Positive news regarding partnerships with Pfizer and progress in the oncology pipeline are driving interest.
- Positive Clinical Results for SA102 CAR-T Therapy: (30%) Positive clinical results for SA102 CAR-T therapy are boosting interest in the company's stock.
- Chinese Biotech Market and Momentum: (25%) 3SBio is highlighted as a key player in the Chinese biotech market, with discussions around momentum and growth.
  
Most Critical Themes:
- Criticism of Pfizer: (5%) Some posts express negative sentiment towards Pfizer.
  
  
  
### Market Cap: $undefined
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$1530hk/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$1530hk/time-series/market_cap.tsv)  
Current Value: $undefined  
Daily Average: $XXXXXXXXXXXXXX  
1-Year High: $XXXXXXXXXXXXXX on 2025-04-01  
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-10  

### Top 3SBio Inc. News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Pfizer Partner 3SBio To Raise $XXX Million In Stock Sale"  
[News Link](https://www.forbes.com/sites/forbeschina/2025/12/02/pfizer-partner-3sbio-to-raise-400-million-in-stock-sale/) [@Forbes](/creator/x/Forbes) 2025-12-03T09:00Z 228.6M followers, XX engagements



### Top 3SBio Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Partnership follows tie-up with China's 3SBio earlier this year. Read:"  
[X Link](https://x.com/ForbesAsia/status/1998739579843604838) [@ForbesAsia](/creator/x/ForbesAsia) 2025-12-10T13:00Z 31.7K followers, XX engagements


"@CountTwoOne @BrutalMrK @Mookafish Pfizer Inc. said on May XX it had agreed to pay a record $XXXX billion to license an experimental cancer drug from Chinas 3SBio Inc. Bristol-Myers Squibb Co. said it would pay Germanys BioNTech SE as much as $XXXX billionto license a cancer drug that BioNTech had itself"  
[X Link](https://x.com/GeZhu13/status/1996384514831266293) [@GeZhu13](/creator/x/GeZhu13) 2025-12-04T01:02Z XX followers, XXX engagements


"3SBio's valuation logic shifting away from Mandi focusing on innovative drug R&D for future growth and potential to surpass peers with good clinical data. 3SBio has big upside based on Placing price"  
[X Link](https://x.com/crisswang276/status/1996384050957983939) [@crisswang276](/creator/x/crisswang276) 2025-12-04T01:00Z XX followers, XX engagements


"China-headquartered 3SBio will mostly use the funds for R&D. Read:"  
[X Link](https://x.com/ForbesAsia/status/1996142422535901655) [@ForbesAsia](/creator/x/ForbesAsia) 2025-12-03T09:00Z 31.7K followers, XX engagements